Photo of Susan  Sprich, PhD

Susan Sprich, PhD

  • Director, Cognitive Behavioral Therapy Program, MGH


Accepting New Patients




Clinical Interests
  • Anxiety disorders
  • Obsessive compulsive spectrum disorders
  • Trichotillomania
  • Cognitive Behavioral Therapy (CBT)
  • Attention deficit hyperactivity disorder (ADHD)
Medical Education
  • PhD, SUNY at Albany
  • Fellowship, Massachusetts General Hospital
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna Behavioral Health
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Vermont
  • TriCare
  • Tufts Health Plan
  • United Behavioral Health
  • United Behavioral Health - MGH
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


Dr. Sprich is the Director of the Cognitive-Behavioral Therapy Program at Massachusetts General Hospital (MGH). She is also the Director of Postgraduate Psychology Education at the Psychiatry Academy at MGH.  She received her doctorate in clinical psychology from the State University of New York at Albany. She is an Assistant Professor in Psychology at Harvard Medical School. Her primary research interests are cognitive-behavioral treatment of ADHD in adults and adolescents, and cognitive-behavioral treatment of OC-Spectrum disorders in children, adolescents in adults. Clinically, she treats individuals with anxiety, ADHD, mood and OC-Spectrum disorders. She also teaches seminars and does supervision with the interns and residents at MGH.

Research & Publications

Research Summary
My main research focus is on ADHD in adults and children. My first study in this area examined the link between perinatal complications and ADHD. Subsequently, I found a lower rate of ADHD in adoptive relatives of children with ADHD compared to the rate of ADHD in biological relatives of children with ADHD. I was a co-investigator on an NIMH R-03, which was the first U.S. study to provide empirical support for a psychosocial treatment for ADHD in medication treated adults with residual symptoms. I was a co-investigator on an NIMH-R01 testing the efficacy of this intervention. I was also the co-PI on an NIMH R-34 grant evaluating our psychosocial treatment for ADHD in high school students. I have been an active investigator in other research projects including a research project examining the impact of D-cycloserine administration in the CBT treatment of children and adolescents with OCD (D.Geller, PI). Currently, I am involved in a grant examining CBT for Body Dysmporphic Disorder (Wilhelm, PI) and CBT for young men with Autism Spectrum Disorders (Henin, PI).

Selected Publications:
Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto M (2010). Cognitive Behavioral Therapy vs Relaxation with Educational Support for Medication-Treated Adults with ADHD and Persistent Symptoms; A Randomized Controlled Trial. Journal of the American Medical Association, 304(8), 875-880.

Safren SA, Perlman CA, Sprich S, Otto MW. Mastery of your adult ADHD. Client Workbook. Oxford University Press, 2005.

Safren SA, Sprich S, Perlman CA, Otto MW. Mastery of your adult ADHD, Therapist Manual. Oxford University Press, 2005.


One Bowdoin Square
Boston, 02114-2927
Phone: 617-726-5991
Fax: 617-724-8690

Back to Top